ASENSUS SURGICAL, INC.
TRXDWHealthcare · Surgical & Medical Instruments & Apparatus · DE · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | |
|---|---|---|---|---|---|---|
| Revenue | $8.6M | $7.1M | $8.2M | $3.2M | $8.5M | $24.1M |
| Operating income | −$79.5M | −$75.7M | −$64.6M | −$60.4M | −$154.6M | −$49.2M |
| Net income | −$78.4M | −$75.6M | −$62.5M | −$59.3M | −$154.2M | −$61.8M |
| Total assets | $59.1M | $116.1M | $186.5M | $78.3M | $74.8M | $239.3M |
| Total liabilities | $25.7M | $16.4M | $17.2M | $16.7M | $19.2M | $70.8M |
| Equity | $33.4M | $99.6M | $169.2M | $61.6M | $55.5M | $168.5M |
| EPS (diluted) | $-0.31 | $-0.32 | $-0.28 | — | — | — |
| Shares out. | 239.3M | 236.4M | 232.6M | 46.1M | 217.0M | 200.0M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2023- Operating margin
- −926.5%
- Net margin
- −914.5%
- Return on equity
- −234.7%
- Return on assets
- −132.7%
- Return on capital (ROCE)
- −171.1%
- Liabilities / assets
- 43.4%
- Debt / equity
- 0.77×
- Book value / share
- $0.14
- Revenue growth (YoY)
- 21.0%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2023- Altman Z″ (distress)
- -56.86distress
- Accruals / assets
- −25.1%clean
- Piotroski F-Score
- 3/9weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 2 severe● 3 warning● 3 good- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- Negative operating cash flow
- Revenue is growing year-over-year
- Conservative leverage (liabilities < 50% of assets)
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗Nov 15, 2007
- NT 10-Qmissed a reporting deadline ↗May 16, 2006
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Material events
SEC Form 8-K · most recent- Completed an acquisition or disposition · Delisting / listing-standard notice · Modified shareholder rights · Change in control · Director / officer change · Amended charter or bylaws · Other material eventAug 22, 2024
- Shareholder voteAug 20, 2024
- Results of operationsAug 13, 2024
- Other material eventJul 29, 2024
- Entered a material agreement · Other material eventJun 7, 2024
- Results of operationsMay 15, 2024
- Item 5.08May 15, 2024
- Entered a material agreement · New financial obligation · Modified shareholder rights · Other material eventApr 3, 2024
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- SC 13G/ANov 13, 2024
- 15-12GFORM 15-12GSep 3, 2024
- EFFECTAug 26, 2024
- EFFECTAug 26, 2024
- EFFECTAug 26, 2024
- EFFECTAug 26, 2024
- EFFECTAug 26, 2024
- 25-NSEAug 22, 2024
- S-8 POSFORM S-8 POSAug 22, 2024
- S-8 POSFORM S-8 POSAug 22, 2024
- S-8 POSFORM S-8 POSAug 22, 2024
- S-8 POSFORM S-8 POSAug 22, 2024
- S-8 POSFORM S-8 POSAug 22, 2024
- S-8 POSFORM S-8 POSAug 22, 2024
- S-8 POSFORM S-8 POSAug 22, 2024
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.